Fear of cancer recurrence in young women 5 years after diagnosis with a good-prognosis cancer: the VICAN-5 national survey

被引:10
|
作者
Magnani, Clement [1 ]
Ben Smith, Allan [2 ,3 ]
Rey, Dominique [4 ]
Sarradon-Eck, Aline [4 ,5 ]
Preau, Marie [6 ,7 ]
Bendiane, Marc-Karim [4 ]
Bouhnik, Anne-Deborah [4 ]
Mancini, Julien [8 ]
机构
[1] Aix Marseille Univ, Marseille, France
[2] Ingham Inst Appl Med Res, Sydney, NSW, Australia
[3] Univ New South Wales, South Western Sydney Clin Sch, Liverpool, NSW, Australia
[4] Aix Marseille Univ, Equipe CANBIOS Labellisee Ligue 2019, INSERM,IRD,ISSPAM, SESSTIM,Sci Econ & Sociales Sante & Traitement In, Marseille, France
[5] Inst Paoli Calmettes, SESSTIM, Marseille, France
[6] Unite UMR 1296 Radiat Def Sante Environm, Lyon, France
[7] Univ Lumiere Lyon 2, Inst Psychol, Bron, France
[8] Aix Marseille Univ, Hop Timone,BioSTIC,Biostat & Technol Informat & C, AP HM,ISSPAM,Equipe CANBIOS Labellisee Ligue 2019, INSERM,IRD,SESSTIM,Sci Econ & Sociales Sante & Tr, Marseille, France
关键词
Cancer survivors; Fear of recurrence; General practitioner; Breast; Thyroid; Melanoma; QUALITY-OF-LIFE; FOLLOW-UP CARE; BREAST-CANCER; HEALTH LITERACY; SURVIVORS; ASSOCIATION; PROGRESSION; PREVALENCE; VALIDATION; DEPRESSION;
D O I
10.1007/s11764-022-01193-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Fear of cancer recurrence (FCR) is frequent in survivors, but less is known about FCR in long-term survivors with very low risk of relapse. Our aim was to estimate the prevalence and clinical and socio-behavioural factors associated with FCR in young women 5 years after diagnosis of a good-prognosis cancer. Methods Using data from the VICAN-5 survey, conducted in 2015-2016 amongst a national representative French sample of cancer survivors, we included women with non-metastatic melanoma, breast, or thyroid cancer, aged 55 years or under at diagnosis, who experienced no disease progression in the 5 years post-diagnosis. Multinomial logistic regression was used to identify factors associated with FCR, characterised using a three-level indicator: no, mild, and moderate/severe FCR. Results Amongst the 1153 women included, mean age was 44 years at diagnosis, and 81.8% had breast cancer, 12.5% thyroid cancer, and 5.8% melanoma. Five years after diagnosis, 35.4% reported no FCR, 46.0% mild FCR, and 18.6% moderate/severe FCR. Women with thyroid cancer were less likely to suffer from mild or moderate/severe FCR, while cancer-related treatment sequelae, fatigue, and anxiety were more likely. Limited health literacy was associated with mild FCR. Women who reported only occasionally consulting a general practitioner (GP) for the management of their cancer had a higher probability of FCR. Conclusion Moderate/severe FCR affected nearly 20% of young female long-term survivors diagnosed with a good-prognosis cancer, particularly those reporting cancer-related sequelae, suffering from fatigue or anxiety, with breast cancer or melanoma (versus thyroid cancer), and consulting a GP only occasionally for cancer management. I mplications for Cancer Survivors Given the recognised impact of FCR on quality of life, it is essential to detect it as early as possible, and to implement targeted interventions in routine care.
引用
收藏
页码:1359 / 1370
页数:12
相关论文
共 50 条
  • [21] Breast reconstruction and quality of life five years after cancer diagnosis: VICAN French National cohort
    Memoli Victoria
    Bannier Marie
    Rey Dominique
    Alleaume Caroline
    Ben Diane Marc-Karim
    Mancini Julien
    Lauzier Sophie
    Bouhnik Anne-Déborah
    Breast Cancer Research and Treatment, 2022, 194 : 449 - 461
  • [22] COMPARISON OF CLINICOPATHOLOGICAL CHARACTERISTICS AND PROGNOSIS BETWEEN ≤5 YEARS AND >5 YEARS RECURRENCE AFTER CURATIVE SURGERY FOR COLORECTAL CANCER
    Kim, H.
    Huh, J.
    Lee, W.
    Kim, H.
    Yun, S.
    Cho, Y.
    Park, Y.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E282 - E282
  • [23] PROGNOSIS AFTER 5 YEARS OF EXERESIS FOR CANCER OF COLON
    ROUX, M
    VAYRE, P
    HUREAU, J
    LEVASSEU.JC
    ARCHIVES FRANCAISES DES MALADIES DE L APPAREIL DIGESTIF, 1973, 62 (08): : 704 - 704
  • [24] Sexual desire of French representative prostate cancer survivors 2 years after diagnosis (the VICAN survey)
    Magali Girodet
    Anne-Déborah Bouhnik
    Julien Mancini
    Patrick Peretti-Watel
    Marc-Karim Bendiane
    Isabelle Ray-Coquard
    Marie Preau
    Supportive Care in Cancer, 2019, 27 : 2517 - 2524
  • [25] Sexual desire of French representative prostate cancer survivors 2years after diagnosis (the VICAN survey)
    Girodet, Magali
    Bouhnik, Anne-Deborah
    Mancini, Julien
    Peretti-Watel, Patrick
    Bendiane, Marc-Karim
    Ray-Coquard, Isabelle
    Preau, Marie
    SUPPORTIVE CARE IN CANCER, 2019, 27 (07) : 2517 - 2524
  • [26] Breast reconstruction and quality of life five years after cancer diagnosis: VICAN French National cohort
    Victoria, Memoli
    Marie, Bannier
    Dominique, Rey
    Caroline, Alleaume
    Marc-Karim, Ben Diane
    Julien, Mancini
    Sophie, Lauzier
    Anne-Deborah, Bouhnik
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 194 (02) : 449 - 461
  • [27] Social and Sexual Health of Thyroid Cancer Survivors Two and Five Years After Diagnosis: The VICAN Survey
    Creff, Gwenaelle
    Jegoux, Franck
    Bendiane, Marc-Karim
    Babin, Emmanuel
    Licaj, Idlir
    ORAL ONCOLOGY, 2021, 118
  • [28] Evolution of physical activity and body weight changes in breast cancer survivors five years after diagnosis- VICAN 2 & 5 French national surveys
    Rey, Dominique
    Touzani, Rajae
    Bouhnik, Anne-Deborah
    Rousseau, Frederique
    Monet, Adeline
    Preau, Marie
    Bendiane, Marc-Karim
    Mancini, Julien
    BREAST, 2021, 59 : 248 - 255
  • [29] Fear of cancer recurrence at 2.5 years after a cancer diagnosis: a cross-sectional study in Denmark
    Linda Aagaard Rasmussen
    Henry Jensen
    Anette Fischer Pedersen
    Peter Vedsted
    Supportive Care in Cancer, 2022, 30 : 9171 - 9180
  • [30] Fear of cancer recurrence at 2.5 years after a cancer diagnosis: a cross-sectional study in Denmark
    Rasmussen, Linda Aagaard
    Jensen, Henry
    Pedersen, Anette Fischer
    Vedsted, Peter
    SUPPORTIVE CARE IN CANCER, 2022, 30 (11) : 9171 - 9180